Wordt geladen...
Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
The central importance of angiogenesis and our understanding of how new blood vessels are formed have led to the development of novel antiangiogenic therapies. Although the number of agents in development has grown exponentially, only one phase III trial in breast cancer has been completed. In that...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC400679/ https://ncbi.nlm.nih.gov/pubmed/15084233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr782 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|